Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Genomics England Limited
London
EC1M 6BQ
UK
Contact person: Nick Maltby
Telephone: +44 2078825922
E-mail: nick.maltby@genomicsengland.co.uk
NUTS: UKI31
Internet address(es)
Main address: https://www.genomicsengland.co.uk
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://www.genomicsengland.co.uk/library-and-resources/
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Decision support systems and services for rare disease in genomics.
Reference number: GeL 17/02
II.1.2) Main CPV code
85148000
II.1.3) Type of contract
Services
II.1.4) Short description
Genomics England wishes to procure one or more decision support providers to support it in the remainder of the 100KGP and to support the national genomic service until at least 2020 as more particularly described in the tender documents.
II.1.5) Estimated total value
Value excluding VAT:
6 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Genomics England requires the services to be provided from the UK.
II.2.4) Description of the procurement
Genomics England has a requirement for a decision support system and services for rare disease for the remainder of the 100 000 Genomes Project (100KGP) and potentially the commencement of the NHS Genomic Medicine Service in October 2018.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
6 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/05/2018
End:
31/12/2020
This contract is subject to renewal: Yes
Description of renewals:
The contract may be renewed for up to 2 periods of 1 year.
II.2.9) Information about the limits on the number of candidates to be invited
Envisaged minimum number: 3
Objective criteria for choosing the limited number of candidates:
The top 3- 5 candidates will proceed to the ITT stage.
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Restricted procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
08/12/2017
Local time: 17:00
IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates
Date:
08/01/2018
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until:
23/08/2018
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
The Contracting Authority expressly reserves the right (i) not to award any contract as a result of the procurement process commenced by publication of this notice; and (ii) to make whatever changes it may see fit to the content and structure of the tendering competition; and in no circumstances will the Contracting Authority be liable for any costs incurred by the candidates. Any expenditure, work or effort undertaken prior to contract award is accordingly a matter solely for the commercial judgement of potential suppliers.
a) Genomics England reserves the right at any stage to reject or disqualify or revise the pre-qualified status of any Tenderer who:
1. Provides information or confirmations which later prove to be untrue or incorrect; and/or
2. Does not submit a tender in accordance with the requirements of this ITT or as directed by Genomics England during the procurement process; and/or
3. Fulfils any one or more of the criteria detailed in the Public Contracts Regulations 2016 pertaining to Mandatory Exclusions.
The services may be provided to Genomics England and through Genomics England, which will hold the contract, to any NHS body who may require the Tenderer to provide services to Genomics England on its behalf (and any future successors to these organizations).including the following:
Acute trust (NHS).
Ambulance trusts.
Care trusts.
Central government departments, their agencies and non-departmental public bodies.
Department of Health..
Department of Health arm's length bodies.
General practitioners.
Local health boards.
Mental health trusts.
NHS
NHS England
NHS foundations trusts.
NHS hospital trusts.
Public Health England.
Special health authorities.
Strategic health authorities.
and companies or similar entities established by any of the above including joint ventures with other NHS bodies.
b) Further information on Genomics England may be found at https://www.genomicsengland.co.uk/
c) All discussions and meetings will be conducted in English.
d) Tenders and supporting documents must be priced in GBP and all payments under the contract will be made in sterling.
e) Genomics England may interview any or all economic operators who express an interest in tendering for this work.
f) The value stated at II.1.3) is the best estimate of Genomics England based on what Genomics England believes it would cost to build and run a similar system.
VI.4) Procedures for review
VI.5) Date of dispatch of this notice
02/11/2017